Literature DB >> 15045695

Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia.

Takuya Watanabe1, Shinji Koba, Mitsuharu Kawamura, Masashi Itokawa, Tsunenori Idei, Yukiko Nakagawa, Takashi Iguchi, Takashi Katagiri.   

Abstract

Vascular dementia (VaD) and Alzheimer's disease (AD) are the most common causes of dementia in the elderly. The aim of this study was to investigate carotid atherosclerosis, serum lipid profiles, and atherogenic hormone levels in nondiabetic Japanese men with VaD or AD. Carotid artery intima-media thickness (IMT) and plaque, serum lipid and lipoprotein profiles, including low-density lipoprotein (LDL) particle size, as well as insulin-like growth factor-I (IGF-I, somatomedin C) and testosterone levels, were determined in 34 patients with AD, 37 patients with VaD, and 63 healthy male controls. Age, body mass index, systolic and diastolic blood pressure, and fasting plasma glucose, hemoglobin A(1c) (HbA(1c)), triglyceride, high-density lipoprotein (HDL)-cholesterol, and apolipoproteins (apo) A-I, B, and E levels did not differ significantly among the 3 groups. However, the mean value of carotid IMT, the frequency of atherosclerotic plaque deposition, the serum levels of LDL-cholesterol, lipoprotein(a), and lipid peroxides, and the incidence of small dense LDL (particle diameter </= 25.5 nm) were increased significantly in VaD patients compared with AD patients or controls. VaD patients had a close reverse correlation between carotid IMT and LDL particle diameter, which were statistically proven independent risk factors for VaD. In contrast, AD patients had significantly lower serum levels of IGF-I and testosterone than either VaD patients or controls. Our results indicate that VaD is associated with atherogenic dyslipidemia, in particular, small dense LDL and carotid atherosclerosis, whereas AD is associated with hyposomatomedinemia and hypogonadism rather than atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045695     DOI: 10.1016/j.metabol.2003.11.020

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  20 in total

Review 1.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Authors:  Emily R Rosario; Lilly Chang; Elizabeth H Head; Frank Z Stanczyk; Christian J Pike
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

Review 4.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

5.  Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women : A 10-year follow-up.

Authors:  Matej Bendzala; Peter Sabaka; Martin Caprnda; Andrea Komornikova; Maria Bisahova; Ruth Baneszova; Daniel Petrovic; Robert Prosecky; Luis Rodrigo; Peter Kruzliak; Andrej Dukat
Journal:  Wien Klin Wochenschr       Date:  2017-09-14       Impact factor: 1.704

6.  Interaction of APOE genotype and testosterone on episodic memory in middle-aged men.

Authors:  Matthew S Panizzon; Richard Hauger; Hong Xian; Eero Vuoksimaa; Kelly M Spoon; Sally P Mendoza; Kristen C Jacobson; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Jeanne M McCaffery; Michael J Lyons; William S Kremen; Carol E Franz
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

Review 7.  Sex and the development of Alzheimer's disease.

Authors:  Christian J Pike
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 8.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

Review 9.  Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

Authors:  Emily R Rosario; Christian J Pike
Journal:  Brain Res Rev       Date:  2007-07-07

Review 10.  Androgen cell signaling pathways involved in neuroprotective actions.

Authors:  Christian J Pike; Thuy-Vi V Nguyen; Martin Ramsden; Mingzhong Yao; M Paul Murphy; Emily R Rosario
Journal:  Horm Behav       Date:  2007-11-22       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.